| 0 (0%) | 04-19 02:36 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 45.45 | 1-year : | 46.24 |
| Resists | First : | 38.91 | Second : | 39.59 |
| Pivot price | 38.86 |
|||
| Supports | First : | 37.83 | Second : | 31.47 |
| MAs | MA(5) : | 38.29 |
MA(20) : | 38.83 |
| MA(100) : | 38.36  |
MA(250) : | 38.04 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 11 |
D(3) : | 10.9 |
| RSI | RSI(14): 41.3 |
|||
| 52-week | High : | 41.58 | Low : | 35.45 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ CHT ] has closed above bottom band by 11.4%. Bollinger Bands are 21.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 38.27 - 38.49 | 38.49 - 38.69 |
| Low: | 37.47 - 37.76 | 37.76 - 38.02 |
| Close: | 37.75 - 38.16 | 38.16 - 38.54 |
Thu, 18 Apr 2024
The UAE's Largest Higher Education Institution, Higher Colleges of Technology, Selects YuJa Video Platform to Serve ... - Business Wire
Wed, 17 Apr 2024
Age Alone Is No Barrier to Allo-HCT for AML, Data Indicate - AJMC.com Managed Markets Network
Thu, 28 Mar 2024
Florida-Based Playwright Speaks On "Eating Blackberries" Premiering at HCT April 5 - WHKY
Wed, 20 Mar 2024
Syrian Arab Republic: Overview of Humanitarian Response (HCT Coordinated Response) January-December 2023 ... - ReliefWeb
Fri, 01 Mar 2024
Tissue & Tissue Products - FDA.gov
Fri, 23 Feb 2024
Similar HRQOL With Gilteritinib vs Placebo in FLT3-ITD+ AML Post-HCT - Targeted Oncology
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 776 (M) |
| Shares Float | 4,440 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 2.2 (%) |
| Shares Short | 283 (K) |
| Shares Short P.Month | 255 (K) |
| EPS | 1.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 49.27 |
| Profit Margin | 16.5 % |
| Operating Margin | 17.9 % |
| Return on Assets (ttm) | 5.6 % |
| Return on Equity (ttm) | 9.6 % |
| Qtrly Rev. Growth | 4 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 287.72 |
| EBITDA (p.s.) | 106.09 |
| Qtrly Earnings Growth | -2.3 % |
| Operating Cash Flow | 74,560 (M) |
| Levered Free Cash Flow | 36,130 (M) |
| PE Ratio | 25.95 |
| PEG Ratio | 0 |
| Price to Book value | 0.77 |
| Price to Sales | 0.13 |
| Price to Cash Flow | 0.39 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|